JP2015518869A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518869A5
JP2015518869A5 JP2015515488A JP2015515488A JP2015518869A5 JP 2015518869 A5 JP2015518869 A5 JP 2015518869A5 JP 2015515488 A JP2015515488 A JP 2015515488A JP 2015515488 A JP2015515488 A JP 2015515488A JP 2015518869 A5 JP2015518869 A5 JP 2015518869A5
Authority
JP
Japan
Prior art keywords
poly
acid
lactide
glycolide
hydroxybutyric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015515488A
Other languages
English (en)
Japanese (ja)
Other versions
JP6101346B2 (ja
JP2015518869A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/061343 external-priority patent/WO2013182503A1/en
Publication of JP2015518869A publication Critical patent/JP2015518869A/ja
Publication of JP2015518869A5 publication Critical patent/JP2015518869A5/ja
Application granted granted Critical
Publication of JP6101346B2 publication Critical patent/JP6101346B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015515488A 2012-06-08 2013-06-03 ラパマイシン−40−o−環状炭化水素エステル、組成物及び方法 Active JP6101346B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261657049P 2012-06-08 2012-06-08
US61/657,049 2012-06-08
PCT/EP2013/061343 WO2013182503A1 (en) 2012-06-08 2013-06-03 Rapamycin 40-o-cyclic hydrocarbon esters, compositions and methods

Publications (3)

Publication Number Publication Date
JP2015518869A JP2015518869A (ja) 2015-07-06
JP2015518869A5 true JP2015518869A5 (enExample) 2017-03-09
JP6101346B2 JP6101346B2 (ja) 2017-03-22

Family

ID=48577737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015515488A Active JP6101346B2 (ja) 2012-06-08 2013-06-03 ラパマイシン−40−o−環状炭化水素エステル、組成物及び方法

Country Status (11)

Country Link
US (3) US9408884B2 (enExample)
EP (1) EP2859001B1 (enExample)
JP (1) JP6101346B2 (enExample)
CN (1) CN104203959B (enExample)
AU (1) AU2013270798B2 (enExample)
CA (1) CA2869102C (enExample)
DK (1) DK2859001T3 (enExample)
ES (1) ES2574522T3 (enExample)
PL (1) PL2859001T3 (enExample)
SG (1) SG11201405777YA (enExample)
WO (1) WO2013182503A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408884B2 (en) * 2012-06-08 2016-08-09 Biotronik Ag Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
US10751450B2 (en) * 2012-06-08 2020-08-25 Biotronik Ag Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
US11395853B2 (en) 2016-06-23 2022-07-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions
CN107759616B (zh) * 2016-08-23 2020-11-17 上海微创医疗器械(集团)有限公司 一种化合物及其制备方法和用途
SG11201900602XA (en) 2016-09-19 2019-02-27 Biotronik Ag Polymer-free drug eluting vascular stents
EP3558407B1 (en) 2016-12-22 2023-03-15 Biotronik AG Drug releasing coatings for medical devices and methods of making same
WO2019110600A1 (en) * 2017-12-06 2019-06-13 Biotronik Ag Intracranial drug delivery materials and methods
EP4699663A3 (en) * 2018-02-23 2026-05-06 Biotronik Ag Parenteral formulation materials and methods for 40-o-cyclic hydrocarbon esters and related structures
EP3613449A1 (de) * 2018-08-23 2020-02-26 Biotronik Ag Verbesserung der polymerschicht bei degradierbaren vorrichtungen
EP3917587A1 (en) * 2019-01-30 2021-12-08 Biotronik Ag Covered stent for local drug delivery
EP3708176A1 (en) 2019-03-15 2020-09-16 Centre National De La Recherche Scientifique -Cnrs- Mutant vsv ectodomain polypeptide and uses thereof
WO2022023414A2 (en) * 2020-07-29 2022-02-03 Biotronik Ag Pharmaceutical microsphere compositions and methods
US20240100025A1 (en) * 2020-12-14 2024-03-28 Biotronik Ag Materials and Methods for Treating Viral and Other Medical Conditions
CN119907670A (zh) * 2022-09-30 2025-04-29 百多力股份公司 用于血管通路瘘、移植物和其它血管疾病的血管周围医学治疗的大环三烯免疫抑制化合物
EP4594329A1 (en) * 2022-09-30 2025-08-06 Biotronik Ag Synthesis and characterization of cyclic hydrocarbon esters of everolimus
GB202415232D0 (en) 2024-10-16 2024-11-27 Nacamed As Composition

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3993749A (en) 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4316885A (en) 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
ZA892859B (en) 1988-04-22 1989-12-27 Advanced Polymer Systems Inc Porous particles in preparations involving immiscible phases
US5120842A (en) 1991-04-01 1992-06-09 American Home Products Corporation Silyl ethers of rapamycin
US5100883A (en) 1991-04-08 1992-03-31 American Home Products Corporation Fluorinated esters of rapamycin
US5118678A (en) 1991-04-17 1992-06-02 American Home Products Corporation Carbamates of rapamycin
US5102876A (en) 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin
US5138051A (en) 1991-08-07 1992-08-11 American Home Products Corporation Rapamycin analogs as immunosuppressants and antifungals
US5118677A (en) 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
US5120727A (en) 1991-05-29 1992-06-09 American Home Products Corporation Rapamycin dimers
US5120725A (en) 1991-05-29 1992-06-09 American Home Products Corporation Bicyclic rapamycins
US5151413A (en) 1991-11-06 1992-09-29 American Home Products Corporation Rapamycin acetals as immunosuppressant and antifungal agents
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5258389A (en) 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
US5310903A (en) 1993-03-05 1994-05-10 Merck & Co., Inc. Imidazolidyl rapamycin derivatives
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5385910A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Gem-distributed esters of rapamycin
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US6939376B2 (en) * 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
CN101467921B (zh) * 2001-11-05 2012-08-15 生物传感器国际集团有限公司 药物洗脱支架的生产方法
US7160867B2 (en) * 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
EP1663343B8 (en) 2003-09-15 2019-12-04 Atrium Medical Corporation Application of a therapeutic substance to a tissue location using an expandable medical device
CA2544731A1 (en) * 2003-11-03 2005-05-12 Altachem Pharma Ltd. Rapamycin peptides conjugates: synthesis and uses thereof
EP1737869A1 (en) * 2004-04-14 2007-01-03 Wyeth a Corporation of the State of Delaware Regiospecific synthesis of rapamycin 42-ester derivatives
US7214759B2 (en) 2004-11-24 2007-05-08 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same
US8021678B2 (en) * 2006-02-10 2011-09-20 Advanced Cardiovascular Systems, Inc. Implantable medical device with polymer coating in a surface area to volume ratio providing surface erosion characteristics
US7678901B2 (en) * 2006-02-28 2010-03-16 Wyeth Rapamycin analogs containing an antioxidant moiety
KR20080106225A (ko) * 2006-03-07 2008-12-04 와이어쓰 마크롤라이드 면역억제제의 수용성 폴리에틸렌 글리콜 콘쥬게이트를 제조하는 방법
US7867988B2 (en) 2006-09-13 2011-01-11 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
WO2009131631A1 (en) * 2008-04-14 2009-10-29 Poniard Pharmaceuticals, Inc. Rapamycin analogs as anti-cancer agents
WO2012017449A1 (en) * 2010-08-04 2012-02-09 Meril Life Sciences Pvt. Ltd Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties"
CN102018996B (zh) * 2010-12-14 2013-03-06 中国医学科学院生物医学工程研究所 一种表面固定有抗体的药物血管支架的制备方法
DE102011010539A1 (de) 2011-02-07 2012-08-09 Airbus Operations Gmbh Aufrüstvorrichtung und Verfahren zur Herstellung einer aus einem Faserverbundwerkstoff bestehenden Rumpftonne für ein Luftfahrzeug
US9408884B2 (en) * 2012-06-08 2016-08-09 Biotronik Ag Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods

Similar Documents

Publication Publication Date Title
Tsuji Poly (lactic acid) stereocomplexes: A decade of progress
Bordes et al. Nano-biocomposites: biodegradable polyester/nanoclay systems
BR112014016453A8 (pt) poliésteres à base de ácido 2,5-furan dicarboxílico preparados a partir da biomassa
WO2014100257A3 (en) Fdca-based polyesters made with isosorbide
JP2012526622A5 (enExample)
JP2016528876A5 (enExample)
JP2011519825A5 (enExample)
JP2018189954A5 (enExample)
LT3202814T (lt) Lėto irimo poli-(laktidas/glikolidas) ir polimerų gamybos būdai
JP2017531471A5 (enExample)
ES2571735T3 (es) Composiciones biodegradables que soportan grupo hidrófilo colgante y dispositivos relacionados
JP2010520315A5 (enExample)
Esnaashari et al. A learning automata based scheduling solution to the dynamic point coverage problem in wireless sensor networks
JP2019119840A5 (enExample)
BR112012005223A2 (pt) método de formação de um artigo a partir de polímeros processáveis por não-fusão e artigos formandos a partir dos mesmos
MX2015005890A (es) Poli (acido dihidroferulico) un imitador del polietilenterftalato biorenovable derivado de lignina y acido acetico y copolimeros de los mismos.
JP2015063604A5 (enExample)
JP2009518513A5 (enExample)
JP2014156596A5 (enExample)
JP2013545875A5 (enExample)
WO2011143379A3 (en) Poly(dihydroferulic acid) a biorenewable polyethylene terephthalate mimic derived from lignin and acetic acid
DE602007014248D1 (de) Resorbierbare copolyester von poly(ethoxyethylendiglykolat) und glykolid
JP2016524011A5 (enExample)
JP2005537283A5 (enExample)
JP2007131679A5 (enExample)